2022
DOI: 10.21053/ceo.2020.02362
|View full text |Cite
|
Sign up to set email alerts
|

The Impact of National Health Insurance Coverage on Compliance With Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea

Abstract: Objectives Compliance with positive airway pressure (PAP) in patients with obstructive sleep apnea (OSA) directly affects its treatment efficacy. Since July 2018, polysomnography and PAP therapy have been covered by the national health insurance (NHI), which has reduced the price barrier and promoted PAP therapy in Korea. This study aimed to compare changes in PAP compliance before and after NHI implementation.MethodsThis study is a retrospective analysis in a tertiary hospital setting in Korea. From 2011 to 2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 30 publications
0
6
0
1
Order By: Relevance
“…Previous observational studies have suggested that the long-term maintenance of PAP therapy is influenced by socioeconomic factors and the healthcare system [ 22 ]. Findings from recent Korean observational studies suggest improved long-term compliance with PAP therapy up to 9 months post-implementation of the NHI [ 23 ]. Third, as we only focused on patients undergoing PSG, we may have underestimated the overall prevalence of sleep disorders owing to cases in which patients declined evaluation.…”
Section: Discussionmentioning
confidence: 99%
“…Previous observational studies have suggested that the long-term maintenance of PAP therapy is influenced by socioeconomic factors and the healthcare system [ 22 ]. Findings from recent Korean observational studies suggest improved long-term compliance with PAP therapy up to 9 months post-implementation of the NHI [ 23 ]. Third, as we only focused on patients undergoing PSG, we may have underestimated the overall prevalence of sleep disorders owing to cases in which patients declined evaluation.…”
Section: Discussionmentioning
confidence: 99%
“… 10 30 Portable PSG based on peripheral arterial tonometry was validated, and respiratory indexes of portable PSG were well correlated with those of level 1 PSG. 20 31 PSG is reimbursed by the National Health Insurance for the general population, 32 but there are no standard for the PSG test in pregnant women.…”
Section: Discussionmentioning
confidence: 99%
“…As a result, patient compliance, adherence, and use of PAP therapy increased. 8,9) Since July 2018, the Korean National Health Insurance (NHI) has been covering PAP therapy in patients with moderate-to-severe OSA (apnea hypopnea index [AHI] ≥15) and some complicated patients (lowest SpO2 <85% or lowest SpO2 ≥85% with insomnia, daytime sleepiness, cognitive disorder, mood disorder, hypertension, history of CVD or history of cerebrovascular disease) in mild OSA (5≤AHI<15). However, the salary standard for the use of PAP therapy in the mild OSA group has been strengthened since December 2020.…”
Section: Introductionmentioning
confidence: 99%